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Gisella Armillotta1, Laura Manna1, Fabio Minelli2, Manuela Tittarelli1 and
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1 Istituto Zooprofilattico Sperimentale dell’Abruzzo e del Molise “G. Caporale”, Teramo, Italy, 2 EU Reference Laboratory for
E. coli, Department of Veterinary Public Health and Food Safety, Istituto Superiore di Sanità, Rome, Italy
Monoclonal antibodies (MAbs) specific for the lipopolysaccharide (LPS) of Escherichia
coli O104:H4 were produced by fusion of Sp2/O-Ag-14 mouse myeloma cells with
spleen cells of Balb/c mice, immunized with heat-inactivated and sonicated E. coli
O104:H4 bacterial cells. Four MAbs specific for the E. coli O104:H4 LPS (1E6G6,
1F4C9, 3G6G7, and 4G10D2) were characterized and evaluated for the use in a method
for the detection of E. coli O104:H4 in milk samples that involves antibody conjugation
to magnetic microbeads to reduce time and increase the efficiency of isolation. MAb
1E6G6 was selected and coupled to microbeads, then used for immuno-magnetic
separation (IMS); the efficiency of the IMS method for E. coli O104:H4 isolation from
milk was evaluated and compared to that of the EU RL VTEC conventional culture-
based isolation procedure. Milk suspensions also containing other pathogenic bacteria
that could potentially be found in milk (Campylobacter jejuni, Listeria monocytogenes,
and Staphylococcus aureus) were also tested to evaluate the specificity of MAb-coated
beads. Beads coated with MAb 1E6G6 showed a good ability to capture the E. coli
O104:H4, even in milk samples contaminated with other bacteria, with a higher number
of E. coli O104:H4 CFU reisolated in comparison with the official method (121 and
41 CFU, respectively, at 103 E. coli O104:H4 initial load; 19 and 6 CFU, respectively, at
102 E. coli O104:H4 initial load; 1 and 0 CFU, respectively, at 101 E. coli O104:H4 initial
load). The specificity was 100%.
Keywords: detection, Escherichia coli O104:H4, immuno-magnetic separation, milk, monoclonal antibodies
INTRODUCTION
Escherichia coli (Enterobacteriaceae) is a Gram-negative, facultative anaerobic bacterium that is
commonly found in the lower intestinal tract of healthy animals and humans. However, several
E. coli strains have acquired virulence traits that allow them to cause disease in humans and
animals. At least six categories of pathogenic E. coli able to affect the human gut have been
described: Shiga-toxin-producing E. coli, also called verocytotoxin-producing E. coli (STEC or
VTEC), of which enterohaemorrhagic E. coli (EHEC) are a highly pathogenic sub-group causing
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bloody diarrhea and the hemolytic uremic syndrome (HUS),
characterized by severe acute renal failure, thrombocytopenia
and micro-angiopathic haemolytic anemia (European Centre
for Disease Prevention and Control [ECDC] and European
Food Safety Authority [EFSA], 2011); enteropathogenic E. coli
(EPEC); enterotoxigenic E. coli (ETEC); enteroaggregative E. coli
(EAggEC); enteroinvasive E. coli (EIEC), and attaching and
effacing E. coli (A/EEC) (European Centre for Disease Prevention
and Control [ECDC] and European Food Safety Authority
[EFSA], 2011; Farrokh et al., 2013).
Prior to 2011, STEC serogroup O104 was not considered as
a major STEC serogroup, although it had been associated with
an outbreak of diarrhea in the US and with sporadic cases in
European countries and Korea (European Centre for Disease
Prevention and Control [ECDC] and European Food Safety
Authority [EFSA], 2011; Baranzoni et al., 2014).
The concern about this serogroup increased in May-July 2011,
with the occurrence of two outbreaks of bloody diarrhea and
HUS in Europe: one in Germany (around 4000 cases of bloody
diarrhea, 850 cases of HUS and 50 deaths), and a much smaller
outbreak in southwest France (15 cases of bloody diarrhea, 9
of which progressed to HUS). Both outbreaks were caused by
a STEC strain belonging to serotype O104:H4 and linked to
the consumption of contaminated sprouts from fenugreek seeds
(Grad et al., 2012; Baranzoni et al., 2014). The genetic analysis
of the outbreak strain revealed that it carried virulence genes
associated with both STEC and EaggEC (Bielaszewska et al.,
2011; Scheutz et al., 2011; Baranzoni et al., 2014); in addition,
all isolates also expressed the phenotypes that define STEC and
EaggEC, specifically production of Shiga-toxin 2 (Stx2) and
the aggregative adherence pattern on intestinal epithelial cells,
and were resistant to all penicillins and cephalosporins and to
co-trimoxazole (trimethoprim-sulfamethoxazole). The specific
combination of the higher adherence to intestinal cells, physical
survival, Stx2 production and antibiotic resistance, shows the
high genomic plasticity of E. coli O104:H4 and could explain the
high virulence of the epidemic strain (Bielaszewska et al., 2011;
Scheutz et al., 2011).
The severity of the oubreaks caused by this foodborne
pathogen highlights the need for sensitive screening methods
allowing its rapid identification and isolation from food matrices,
as sprouts, milk and meat.
Raw cow’s and goat’s milk provides a potential growth
medium for bacteria and its consumption has been frequently
associated with STEC infections in Europe, USA and Canada.
Most of these cases were associated with STEC O157, although
other serotypes or serogroups, including O22:H8, O110:H−,
O80:H−, and O145 have been identified as causative agents.
Consumption of contaminated soft and semi-soft cheeses has
also been implicated in outbreaks: E. coli O157:H7 was linked
to the majority of cases, but O27:H20, O103, O26, O145,
O119:B14, O27:H20, and O104:H21 have also been implicated
(Centers for Diseases Control and Prevention [CDC], (1995);
Farrokh et al., 2013). Generally, there are two suggested routes
by which potentially pathogenic STEC can contaminate raw
milk: rare sub-clinical mastitis causing STEC excretion from
the udder and contamination during the milking process, when
teats are soiled with feces. STEC could also potentially persist if
milking equipment is not adequately cleaned. Contamination of
dairy products (cheeses, cream, ice-cream, yogurt and butter) is
commonly due to the use of raw/unpasteurized milk, to defective
pasteurization of milk and/or post processing contamination
(Farrokh et al., 2013).
The aim of this work was the development of an immuno-
magnetic separation (IMS) method based on the use of beads
coated with monoclonal antibodies (MAbs) specific for the
lipopolysaccharide (LPS) of E. coli O104:H4 for the rapid and
efficient isolation of E. coli O104:H4 from milk samples.
MATERIALS AND METHODS
Bacterial Strains
The E. coli O104:H4 strain used for the production and the
screening of MAbs and for the immunomagnetic capture was
isolated from an Italian child with HUS in 2009 (Scavia et al.,
2011). Other five enteroaggregative E. coli O104 strains were
used to test the MAb 1E6G6. These included two VT2-positive
strains and one VT-negative strain kindly provided by the
Statens Seruminstitut (Copenhagen, Denmark), a VT2-positive
strain kindly provided by the Robert Koch Institute (Berlin,
Germany), and another VT2-positive strain kindly provided by
the Hopital Robert Debre (Paris, France). The E. coli O157,
E. coli O26, E. coli O103, E. coli O111, and E. coli O145
strains used for MAbs characterization, were part of the culture
collection of the European Union Reference Laboratory for
E. coli (EU-RL-ISS). Campylobacter jejuni ATCC 33291, Listeria
monocytogenes ATCC 7644, and Staphylococcus aureus ATCC
6538 used to evaluate the specificity of MAbs, were obtained from
ATCC Bacterial Collection LGC.
Preparation of E. coli Antigens for MAbs
Production and Characterization
Escherichia coli O104:H4, E. coli O157, E. coli O26, E. coli O103,
E. coli O111, and E. coli O145 were grown in Brain Heart Infusion
Broth (BHI) (Oxoid, Basingstoke, Hampshire, UK) at 37◦C for
14–16 h, inactivated at 100◦C for 1 h and centrifuged at 5,500 g
for 30 min. The pellet was washed for three times with 0.01 M
phosphate buffered saline, pH 7.2 (PBS), resuspended in PBS and
stored at –20◦C. One aliquot of the E. coli O104:H4 suspension
was sonicated in ice bath for two cycles of 2.5 min each with an
interval of 5 min and immediately used for mice immunization.
The protein concentration of antigen preparations was
determined using the BCA Protein Assay Kit (Pierce Rockford,
IL, USA).
Preparation of the E. coli O104
Lipopolysaccharide
The E. coli O104 LPS was extracted by the hot phenol–water
method (Westphal and Jann, 1965). The LPS was precipitated
with 3 M sodium-acetate and absolute ethanol, ultracentrifuged,
resuspended in deionized water and stored at –80◦C until
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use. The quantity of LPS was determined by the 2-keto-3-
deoxyoctonate (KDO) assay (Karkharis et al., 1978).
Immunization of Mice
For MAbs production, 6/8 week-old Balb/c mice were inoculated
with heat-inactivated and sonicated E. coli O104:H4 preparations.
Animal experimentation was carried out in compliance with
Italian national law (Decreto legislativo 27 Gennaio, 1992,
n. 116) implementing Directive 86/609/EEC of the Council
of the European Communities on the protection of animals
used for experimental and other scientific purposes (European
Commission [EC], 1986). The protocol was approved by the
Italian Ministry of Health with number 5146 of 26.04.2012. The
whole antigen, diluted to a protein concentration of 100 µg/ml,
was emulsified with complete Freund adjuvant (Sigma, St.
Louis, MO, USA) and administered intraperitoneally; 14 days
later a second immunization was performed using the same
concentration of antigen emulsified with incomplete Freund
adjuvant (Sigma). Subsequently, on days 28 and 56, 100 µg/ml
of antigen diluted in PBS was given (intravenous booster). Three
days later, the mice were sacrificed, the spleen collected and
splenocytes subjected to cell fusion with murine myeloma cells
Sp2/O-Ag-14 (ATCC CRL-1581TM).
Characterization of Monoclonal
Antibodies vs. E. coli O104:H4
The antibody-secreting hybridomas, cultured in Dulbecco’s
Modified Eagle’s Medium (DMEM) containing 20% bovine
fetal serum, 2 mM L-glutamine, 100X Penicillin–Streptomycin–
Amphotericin, 50 mg/ml gentamicin and 50X HAT, were
screened by i-ELISA. Briefly, 96-well microplates (PolySorp,
Nunc Brand Products, Roskilde, DK) were coated with 10 µg/ml
of E. coli O104 LPS and of the bacterial whole antigens (E. coli
O104:H4, E. coli O157, E. coli O26, E. coli O103, E. coli O111,
E. coli O145) diluted in 0.05 M carbonate-bicarbonate buffer,
pH 9.6, and incubated overnight at 4◦C. After washing and
blocking with 1% yeast extract in PBS containing 0.05% Tween
20 (PBST) at 37◦C for 1 h, 100 µl/well of MAbs supernatants
were added and incubated for 1 h at 37◦C. As secondary antibody,
ECL anti-mouse IgG conjugated with horseradish peroxidase
(GE Healthcare, Little Chalfont, Buckinghamshire, UK) was used;
the 3,3′,5,5′-tetramethylbenzidine (TMB, Sigma) was adopted as
chromogenic substrate. Microplate reading was performed with
a biophotometer (Bio-Rad, Hercules, CA, USA) at a wavelength
of 450 nm. Clones that showed optical densities (OD450) greater
than or equal to 3 times the OD450 of the negative control (serum
of a naive Balb/c mouse) were considered as positives and were
cloned by the limiting dilution method (Luciani et al., 2006).
MAbs were produced in vitro on a large scale by means of serial
cultures of hybridomas and collection of the supernatants and
were isotyped using the Mouse-Typer Isotyping Panel (Bio-Rad).
For immunoblotting analysis, MAbs with IgG and IgM isotype
were purified on affinity chromatography using, respectively, a
HiTrap rProtein A FF column (GE Healthcare, Uppsala, SW)
and a HiTrap IgM Purification HP column (GE Healthcare),
according to the manufacturer’s instructions.
Purified MAbs were concentrated with 100 kDa cut-
off centrifugal filters (Millipore, Billerica, MA, USA) and
resuspended in PBS. The protein concentration of purified
MAbs was determined by spectrophotometry (Absorbance at
280 nm/IgG molar extinction coefficient).
The heat-treated E. coli O104:H4 suspensions (2.5 µg/well)
were subjected to SDS-PAGE separation at 200 V with NuPAGE
4–12% Bis-Tris Gels Mini (Novex, Life Technologies, Carlsbad,
CA, USA) and transferred onto nitrocellulose membrane with
iBlot Dry Blotting System (Life Technologies). After blocking
with 5% skimmed milk (Fluka Analytical, Sigma-Aldrich) in
PBST for 2 h at room temperature (RT), membrane strips
were incubated overnight at 4◦C with the purified MAbs.
The detection of immune complexes was performed using the
ECL anti-mouse IgG HRP-conjugated (GE Healthcare) and
a chemiluminescent substrate (ECL Select Western Blotting
Detection Reagent, GE Healthcare). The analysis of the results
was performed using the Chemidoc MP (Bio-Rad) and the
Quantity One Quantitation Software version 4.3 (Bio-Rad).
Magnetic Beads Coupling Procedure
Purified MAbs were coupled to Dynabeads M-450 Tosylactivated
(Life Technologies). Twenty-five micro litre of dynabeads were
first washed with 0.1 M sodium phosphate buffer, pH 7.4, and
then incubated with 5 µg of each purified MAb at 37◦C for
24 h using the Dynabeads MX4 Mixer (Life Technologies).
Supernatant was removed and dynabeads were resuspended in
0.1 M Tris containing 0.1% BSA (pH 8.5) and incubated for
4 h at 37◦C with gentle and continuous agitation. Supernatant
was discarded and activated dynabeads were resuspended in PBS
containing 0.1% BSA, 2 mM EDTA (pH 7.4), and stored at 4◦C
until use.
Non-coated dynabeads were also prepared using the same
protocol, but without the incubation with the MAbs (non-
coated-beads control as blank).
Preparation of Bacterial Strains for
Immuno-Magnetic Separation
Escherichia coli O104:H4 was grown in Tryptic Soy Broth (TSB)
(Becton Dickinson, Franklin Lakes, NJ, USA) for 24 h at 37◦C,
and then the cultures were streaked onto Tryptic Soy Agar (TSA)
(Becton Dickinson) plates and incubated for 24 h in aerobic
atmosphere at 37◦C. A well separated colony from the plate was
transferred into 10 ml of TSB and incubated at 37◦C in order
to obtain a bacterial suspension with a turbidity between 2 and
3 McFarland standards. The number of cells in the bacterial
suspension was also estimated by reading the absorbance at
600 nm (OD600). The final concentration of bacterial suspension
was 1011 CFU. The culture was decimally diluted in sterile PBS
(until 10−11); the number of bacteria in each diluted suspension
was confirmed by plating onto MacConkey Agar at 37◦C for 24 h.
Campylobacter jejuni, L. monocytogenes, and S. aureus (pool
of contaminating bacteria) were grown, respectively, on Karmali
Agar, Aloe Agar, and TSA Agar. For each strain, a bacterial
suspension in PBS with a concentration of 0.8 McFarland (about
108 CFU) was prepared.
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Immuno-Magnetic Separation and
Evaluation of MAb-Coated Beads
Specificity
The specificity of MAb-coated beads was first evaluated using
PBS suspensions, prepared as described above, containing
decreasing concentration of E. coli O104:H4 from 106 CFU to 101
CFU. Tests were repeated using E. coli O104:H4 PBS suspensions
containing L. monocytogenes, C. jejuni and S. aureus at the
concentration of 103 CFU each.
One ml of each PBS-diluted bacterial suspension was added
with 25 µl of MAb-activated dynabeads and incubated at 4◦C for
30 min with gentle and continuous agitation. Then, dynabeads
were washed four times with PBS containing 0.1% BSA and 2 mM
EDTA, (pH 7.4), resuspended in 100 µl of PBS, plated onto
MacConkey Agar plates and incubated at 37◦C for 24 h. The same
TABLE 1 | Monoclonal antibodies isotypes.
Clone Isotype
1E6G6 IgG1 anti κ
1F4C9 IgG3 anti κ
3G6G7 IgG1 anti κ
4G10D2 IgG3 anti κ
FIGURE 1 | Characterization of MAbs vs. Escherichia coli O104:H4:
western blotting results. Lane 1: MAb 1E6G6; lane 2: MAb 1F4C9; lane 3:
MAb 3G6G7; lane 4: MAb 4G10D2.
procedure was repeated using non-coated beads to ensure the
absence of aspecific interactions between the non-coated beads
and bacteria.
Inoculation and Enrichment of Milk and
E. coli O104:H4 Detection from
Artificially Contaminated Milk Samples
Six aliquots (9 ml each) of bovine raw milk were artificially
contaminated with 1 ml of each one of the six bacterial
suspensions previously prepared (E. coli O104:H4 concentration
from 106 CFU to 101 CFU). One ml of each E. coli O104:H4
contaminated milk sample was incubated with MAb-coated and
non-coated beads as described above. In the same time, one
ml aliquot of each milk sample was analyzed using the EU RL
VTEC official method, which include an overnight enrichment
step. Aliquots (100 µl) of the IMS-treated samples and of the
enrichment broth cultures prepared according to the EU RL
VTEC method were plated onto MacConkey Agar plates. After
incubation for 24 h at 37◦C in aerobic condition, the colonies
obtained with the EU RL VTEC method and with MAb-coated
beads were enumerated.
To verify the absence of cross-reaction between MAbs and
bacteria other than E. coli O104:H4, the same tests described
above were repeated using four aliquots for each of the six cream
milk samples artificially contaminated with the six bacterial
suspensions at the concentration of E. coli O104:H4 from 106
CFU to 101 CFU and with each species of contaminating bacteria
at the concentration of 103 CFU. Each of four aliquots of the
six milk suspensions were, respectively, plated onto MacConkey
Agar, onto Blood Agar for 24 h at 37◦C in aerobic condition for
L. monocytogenes and S. aureus isolation, and Karmali Agar for
48 h at 42◦C in microaerobic conditions for C. jejuni isolation.
DNA Extraction and PCR for Strains
Typing
Escherichia coli O104:H4 DNA extraction was performed using
the InstaGene Matrix (Bio-Rad) according to manufacturer’s
instructions. Primers used for the PCR assay were specific for the
rfbO104 gene, encoding the O-antigen specific for E. coli O104
(O104rfbO-f 5′ TGAACTGATTTTTAGGATGG 3′; O104rfbO-
r 5′ AGAACCTCACTCAAATTATG 3′, amplicon size 351 bp)
(Bielaszewska et al., 2011). A 50 µl PCR mixture contained:
25 µl 2× TopTaq Master Mix (Qiagen, Venlo, NL) (1.25 units of
TopTaq DNA Polymerase, 1× PCR buffer, dNTPs concentration
0.2 mM each, 1.5 mM MgCl2), 1 µl of each primer at the
concentration of 0.2 µM, 18 µl of Nuclease-Free Water and
5 µl of template DNA. Amplifications were performed using
the GeneAmp R© PCR System 9700 (Applied Biosystems, Life
Technologies) and the following temperature cycling conditions:
initial denaturation at 95◦C for 5 min, followed by 35 cycles of
denaturation at 95◦C for 30 seconds, annealing at 55◦C for 1 min,
extension at 72◦C for 1 min and final extension at 72◦C for 7 min.
The PCR products were resolved by electrophoresis on a 1,5%
agarose gel.
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TABLE 2 | Evaluation of MAb-coated beads specificity using Escherichia
coli O104:H4 PBS pure suspensions.
E. coli O104:H4 in the
initial suspension
(CFU number)
E. coli O104:H4 re-isolated after
immuno-magnetic separation (IMS)
(CFU number)
106 >200
105 >200
104 >200
103 76
102 3
101 0
Statistical Analysis
In order to determine differences between the EU RL VTEC
conventional culture-based isolation procedure and the IMS
method described in this paper, the Wilcoxon test for dependent
samples was applied (confidence interval= 95%).
RESULTS
Characterization of Monoclonal
Antibodies vs. the LPS of E. coli O104:H4
A total of 28 hybridomas were positive against the E. coli
O104:H4 whole heat-treated antigen in indirect ELISA. Four
MAbs (1E6G6, 1F4C9, 3G6G7, and 4G10D2) were found positive
for both the E. coli O104:H4 LPS and whole antigen, and
negative against the other O serogroups tested. MAbs isotypes are
shown in Table 1. Characterization by western blotting revealed
that the four selected MAbs reacted with the LPS of E. coli
O104:H4; Figure 1 shows the ladder-like pattern of LPS bands
with molecular weights between 60 and 15 kDa recognized by the
MAbs. One of the four selected MAbs, MAb 1E6G6, was tested by
slide agglutination against five additional E. coli O104:H4 strains
with positive results and subsequently conjugated to magnetic
microbeads, to be used for a specific IMS of E. coli O104:H4 from
milk samples.
Immuno-Magnetic Separation and
Evaluation of MAb-Coated Beads
Specificity
The results obtained from E. coli O104:H4 re-isolation from
PBS pure bacterial suspensions are shown in Table 2. At E. coli
concentrations higher than or equal to 104, the number of CFU
re-isolated was higher than 200. At the concentrations of 103 and
102 CFU, 76 and 3 CFU, respectively, were re-isolated following
the IMS.
When the E. coli O104:H4 PBS suspensions containing other
bacteria (L. monocytogenes, C. jejuni and S. aureus) were used,
more than 200 E. coli O104:H4 CFU were re-isolated from
suspensions with E. coli concentrations higher than or equal to
103; 19 and 2 CFU were re-isolated from the 102 and 101 CFU
E. coli O104:H4 suspensions, respectively, (Table 3). None of the
contaminating bacteria were captured by the MAb-coated beads.
No aspecific binding between the non-coated beads and the four
bacterial suspensions used in the experiments was observed.
E. coli O104:H4 Detection in Artificially
Contaminated Milk Samples
Table 4 shows the results of the E. coli O104:H4 isolation from
milk samples contaminated with scalar dilutions (from 106 to
101 CFU) of E. coli O104:H4. With the Dynabeads method,
a higher number of E. coli O104:H4 CFU was isolated with
respect to the EU RL method. Similar results were obtained with
milk samples contaminated with E. coli O104:H4 and with other
bacteria (L. monocytogenes, C. jejuni and S. aureus) (Table 5). The
p-value obtained using the Wilcoxon test for dependent samples
was 0.0517 with a confidence interval of 95%.
Moreover, none of the other contaminating bacteria were
captured by MAb-coated beads, as shown by the absence of
growth in the specific media. MAb-coated beads isolates were
further confirmed by PCR: all the bacteria captured by coated
beads were E. coli O104:H4 (Figure 2).
DISCUSSION AND CONCLUSION
Shiga toxin–producing Escherichia coli strains are important
foodborne pathogens that have been responsible for numerous
TABLE 3 | Evaluation of MAb-coated beads specificity using E. coli
O104:H4 PBS suspensions containing contaminating bacteria (Listeria
monocytogenes, Campylobacter jejuni, and Staphylococcus aureus).
E. coli
O104:H4 in
the initial
suspension
(CFU number)
Contaminating
bacteria in the
initial
suspension
(CFU number)
E. coli O104:H4
re-isolated after
IMS (CFU
number)
Contaminating
bacteria
re-isolated after
IMS (CFU
number)
106 103 >200 0
105 103 >200 0
104 103 >200 0
103 103 >200 0
102 103 19 0
101 103 2 0
TABLE 4 | Escherichia coli O104:H4 isolation from artificially contaminated
milk samples in the absence of contaminating bacteria: comparison
between the EU RL VTEC official method and the E. coli O104 Dynabeads
method.
E. coli O104:H4 in
the initial
suspension (CFU
number)
E. coli O104:H4
isolated with the
EU RL method
(CFU number)
E. coli O104:H4
isolated with the
O104 Dynabeads
method (CFU
number)
106 >200 >200
105 159 >200
104 117 >200
103 43 >200
102 8 27
101 0 4
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TABLE 5 | Escherichia coli O104:H4 detection from artificially contaminated milk samples in the presence of contaminating bacteria (L. monocytogenes,
C. jejuni, and S. aureus): comparison between the EU RL VTEC official method and the E. coli O104 Dynabeads method.
E. coli O104:H4 in
the initial
suspension (CFU
number)
Contaminating
bacteria in the
initial suspension
(CFU number)
E. coli O104:H4
isolated with EU
RL method (CFU
number)
E. coli O104:H4
isolated with the
E. coli O104
Dynabeads
method (CFU
number)
S. aureus isolated
with the E. coli
O104 Dynabeads
method (CFU
number on Blood
Agar plate)
L. monocytogenes
isolated with the
E. coli O104
Dynabeads
method (CFU
number on Blood
Agar plate)
C. jejuni isolated
with the E. coli
O104 Dynabeads
method (CFU
number on
Karmali Agar
plate)
106 103 >200 >200 0 0 0
105 103 >200 >200 0 0 0
104 103 137 >200 0 0 0
103 103 41 121 0 0 0
102 103 6 19 0 0 0
101 103 0 1 0 0 0
FIGURE 2 | Electrophoresis of the PCR products. Lane 1: molecular weight marker; lane 2–6: E. coli O104:H4 captured by MAb-coated magnetic beads;
lane 7: positive control (DNA extracted from E. coli O104:H4 ISS-certified); lane 8: negative control (nuclease-free water).
outbreaks of hemorrhagic colitis and HUS worldwide. E. coli
O157:H7 is the most frequently implicated in human disease,
although infections can be caused by other serotypes or
serogroups, as E. coli O104:H4. Consequently it is necessary to
have the availability of rapid, sensitive and specific methods for
food control.
In this study, MAbs vs. E. coli O104:H4 were produced
andcharacterized. The efficiency of the E. coli O104:H4 isolation
from milk samples, using Dynabeads activated with a selected
MAb (1E6G6) specific for E. coli O104:H4 LPS, was evaluated
and compared with that of the EU RL VTEC isolation procedure
(European Reference Laboratory for E.coli [EU-RL VTEC],
2011). The specificity of the adsorbed antibodies was also
evaluated by preparing E. coli O104:H4 suspensions containing
other pathogenic bacteria that could potentially be found in
milk, such as Campylobacter jejuni, Listeria monocytogenes, and
Staphylococcus aureus (Farrokh et al., 2013).
The use of MAbs, instead of polyclonal ones (PAbs), could be a
valid alternative to improve the specificity of pathogen detection.
PAbs may have a lack of homogeneity between lots, due to the
variability of the animal immune response. They may also show
cross-reactions with related pathogens. Conversely, MAbs are
highly specific reagents, easily purified and with batch to batch
homogeneity.
Immuno-magnetic separation is a rapid and sensitive method
that permit the revelation of low concentrations of pathogens
in contaminated matrices. The magnetic beads method has
already been applied for the detection of E. coli O157:H7
(Weagant et al., 2011) and E. coli O104 (Baranzoni et al.,
2014) from sprouts with good results. In particular, Baranzoni
et al. (2014) used commercially available E. coli IMS beads in
association with optimized enrichment conditions of sprouts
samples. The results indicated that the IMS enrichment enhanced
the ability to detect E. coli O104 and reduced the interference
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of background microflora. In our work, we used O104-specific
magnetic beads prepared in-house to detect this pathogen
in artificially contaminated milk samples, skipping the use
of a previous enrichment step. The procedure showed an
analytical sensitivity higher than that of the isolation procedure
included in the official EURL method for E. coli O104. Even
if the statistic analysis gave a value slightly higher than the
expected one, numeric data show that the immunomagnetic
method is more sensitive, particularly at low concentrations of
bacteria.
The MAb-coated beads showed a good capability to capture
E. coli O104:H4 in artificially contaminated milk samples,
even in the presence of other contaminating bacteria, such as
C. jejuni, L. monocytogenes, and S. aureus, with an increase
in the number of CFU re-isolated with respect to the current
official method (>200 and 137 CFU, respectively, at 104 E. coli
O104:H4 initial load; 121 and 41 CFU, respectively, at 103 E.
coli O104:H4 initial load; 19 and 6 CFU, respectively, at 102
E. coli O104:H4 initial load and 1 and 0 CFU, respectively, at
101 E. coli O104:H4 initial load). The Dynabeads method also
showed a good analytical specificity, since no contaminating
bacteria were captured by the MAb-coated beads in both PBS
bacterial suspensions and contaminated milk samples and no
aspecific reactions were obtained with non-coated beads. MAb
1E6G6 was able to retain its antigen-binding activity even
in the presence of a fat matrix such as full cream milk.
Moreover, the direct application of the O104 IMS to a liquid
matrix such as milk, skipping the broth enrichment step that
requires an overnight incubation period, allowed a more rapid
isolation of E. coli O104, with respect to the current official
method.
Thus, magnetic beads linked with the MAb 1E6G6 against
E. coli O104:H4 could be a useful tool for improving the detection
of this E. coli serogroup in milk samples. Further studies are
needed to evaluate the performances of MAb 1E6G6 coated-
beads when matrices other than from milk are tested.
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